GlassScriptPhysician profile
Andre J Nolewajka
NPI 1467456954
$3,871.39
in general payments reported to CMS, 2019-2025
15 companies · $1,979 in 2025
The $1,979 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $330 · 2020: $61.51 · 2021: $483 · 2022: $304 · 2023: $367 · 2024: $347 · 2025: $1,979.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,900 · Travel and Lodging: $792.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,900.41 |
| Travel and Lodging | $792.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,412.20 | 2021-2025 | Cobalt Dr Mri Surescan, Omniasecure Mri Surescan, Aurora Ev-Icd Mri Surescan |
| Abiomed | $375.84 | 2023-2025 | Impella |
| Novartis Pharmaceuticals Corporation | $281.88 | 2020-2024 | |
| Philips North America LLC | $226.30 | 2021 | |
| Amgen INC. | $176.04 | 2019-2022 | |
| Medtronic Vascular, INC. | $156.95 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $88.51 | 2021-2025 | Lifevest |
| Boston Scientific Corporation | $40.59 | 2022-2024 | Angiojet Ultra 5000a |
| Amarin Pharma, INC. | $23.25 | 2020 | |
| Cardiva Medical, INC. | $18.34 | 2022 | |
| Sanofi-Aventis U.S. LLC | $17.83 | 2022 | |
| Janssen Pharmaceuticals, INC | $17.61 | 2019 | |
| Chiesi USA, INC. | $12.20 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $12.01 | 2019 | |
| Gilead Sciences, INC. | $11.84 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andre Nolewajka listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.